- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/48 - Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
Patent holdings for IPC class C07D 211/48
Total number of patents in this class: 105
10-year publication summary
|
11
|
10
|
2
|
6
|
3
|
7
|
5
|
9
|
5
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3386 |
6 |
| Bristol-myers Squibb Company | 4742 |
4 |
| Cognition Therapeutics, Inc. | 45 |
4 |
| Ono Pharmaceutical Co., Ltd. | 421 |
4 |
| Theravance Biopharma R&D IP, LLC | 362 |
4 |
| Grey Wolf Therapeutics Limited | 17 |
4 |
| Massachusetts Institute of Technology | 10251 |
3 |
| The Broad Institute, Inc. | 1977 |
3 |
| Chronos Therapeutics Limited | 19 |
3 |
| Gilead Sciences, Inc. | 2222 |
3 |
| Teijin Pharma Limited | 254 |
3 |
| Suzhou Abogen Biosciences Co., Ltd. | 78 |
3 |
| FUJIFILM Corporation | 30514 |
2 |
| Agios Pharmaceuticals, Inc | 224 |
2 |
| Celgene Corporation | 1410 |
2 |
| DIC Corporation | 3962 |
2 |
| Lek Pharmaceuticals d.d. | 181 |
2 |
| Nagoya Industrial Science Research Institute | 18 |
2 |
| NHWA Pharma. Corporation | 50 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 130 |
2 |
| Other owners | 45 |